Taking aim at HIV replication

被引：7

作者：

Finzi, D ^{[1
]}

Siliciano, RE ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA

来源：

NATURE MEDICINE | 2000年 / 6卷 / 07期

关键词：

D O I：

10.1038/77444

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Impressive progress has been made in the development of drugs that inhibit human immunodeficiency virus replication. A new study indicates that mycophenolic acid, a selective inhibitor of lymphocyte proliferation, might also be useful in controlling viral replication through several mechanisms (pages 762-768).

引用

页码：735 / 736

页数：2

共 14 条

[1] Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo [J].

Chapuis, AG ;

Rizzardi, GP ;

D'Agostino, C ;

Attinger, A ;

Knabenhans, C ;

Fleury, S ;

Acha-Orbea, H ;

Pantaleo, G .

NATURE MEDICINE, 2000, 6 (07) :762-768

[2] IN-VIVO FATE OF HIV-1-INFECTED T-CELLS - QUANTITATIVE-ANALYSIS OF THE TRANSITION TO STABLE LATENCY [J].

CHUN, TW ;

FINZI, D ;

MARGOLICK, J ;

CHADWICK, K ;

SCHWARTZ, D ;

SILICIANO, RF .

NATURE MEDICINE, 1995, 1 (12) :1284-1290

[3] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].

Chun, TW ;

Stuyver, L ;

Mizell, SB ;

Ehler, LA ;

Mican, JAM ;

Baseler, M ;

Lloyd, AL ;

Nowak, MA ;

Fauci, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197

[4] Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy [J].

Dornadula, G ;

Zhang, H ;

VanUitert, B ;

Stern, J ;

Livornese, L ;

Ingerman, MJ ;

Witek, J ;

Kedanis, RJ ;

Natkin, J ;

DeSimone, J ;

Pomerantz, RJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (17) :1627-1632

[5] Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J].

Finzi, D ;

Blankson, J ;

Siliciano, JD ;

Margolick, JB ;

Chadwick, K ;

Pierson, T ;

Smith, K ;

Lisziewicz, J ;

Lori, F ;

Flexner, C ;

Quinn, TC ;

Chaisson, RE ;

Rosenberg, E ;

Walker, B ;

Gange, S ;

Gallant, J ;

Siliciano, RF .

NATURE MEDICINE, 1999, 5 (05) :512-517

[6] Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy [J].

Finzi, D ;

Hermankova, M ;

Pierson, T ;

Carruth, LM ;

Buck, C ;

Chaisson, RE ;

Quinn, TC ;

Chadwick, K ;

Margolick, J ;

Brookmeyer, R ;

Gallant, J ;

Markowitz, M ;

Ho, DD ;

Richman, DD ;

Siliciano, RF .

SCIENCE, 1997, 278 (5341) :1295-1300

[7] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [J].

Gulick, RM ;

Mellors, JW ;

Havlir, D ;

Eron, JJ ;

Gonzalez, C ;

McMahon, D ;

Richman, DD ;

Valentine, FT ;

Jonas, L ;

Meibohm, A ;

Emini, EA ;

Chodakewitz, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :734-739

[8] Population biology of HIV-1 infection:: Viral and CD4+ T cell demographics and dynamics in lymphatic tissues [J].

Haase, AT .

ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :625-656

[9] A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].

Hammer, SM ;

Squires, KE ;

Hughes, MD ;

Grimes, JM ;

Demeter, LM ;

Currier, JS ;

Eron, JJ ;

Feinberg, JE ;

Balfour, HH ;

Dayton, LR ;

Chodakewitz, JA ;

Fischl, MA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733

[10] Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir [J].

Lori, F ;

Jessen, H ;

Lieberman, J ;

Finzi, D ;

Rosenberg, E ;

Tinelli, C ;

Walker, B ;

Siliciano, RF ;

Lisziewicz, J .

JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06) :1827-1832

← 1 2 →